Navigation Links
Clifford Saper, MD, PhD, receives Distinguished Scientist Award from the Sleep Research Society
Date:6/25/2012

BOSTON Clifford Saper, MD, PhD, Chairman of the Department of Neurology at Beth Israel Deaconess Medical Center (BIDMC) and James Jackson Putnam Professor of Neurology and Neuroscience at Harvard Medical School, received the 2012 Distinguished Scientist Award from the Sleep Research Society (SRS). The SRS's highest honor, the award was presented to Saper during the organization's annual meeting in Boston.

Established in 1989, the Distinguished Scientist award recognizes significant, original and sustained scientific contributions of a basic, clinical or theoretical nature to the sleep and circadian research fields. Saper's research explores the brain circuitry that controls basic functions, such as wake-sleep cycles and circadian rhythms, as well as cardiovascular and respiratory function. His laboratory has contributed to the understanding of the ascending arousal systems in the brain, the sleep promoting systems in the brain and between different behavioral states, and the brainstem circuitry controlling autonomic and respiratory activity.

Saper received both his MD and PhD and completed his internship in internal medicine at Washington University School of Medicine in St. Louis before completing a neurology residency at Cornell University Medical Center-New York Hospital. He then joined the faculty of Washington University School of Medicine where, from 1981 to 1985, he served as Assistant and later Associate Professor of Neurology and Anatomy and Neurobiology. In 1986 he joined the faculty of the University of Chicago, where he served as Associate Professor, as the William D. Mabie Professor of Physiology and Neurology, and as Chairman of the Committee on Neurobiology between 1985 and 1992. He joined the faculty of Harvard Medical School in 1992.

Saper served on the Board of Directors of the SRS from 2006 to 2011, and served as SRS President during the 2009-2010 term. He was the Editor-in-Chief of the Journal of Comparative Neurology between 1994 and 2011; serves on the editorial board of the journal Neurology and has held editorial board positions of the journals Brain, the Journal of Neuroscience, SLEEP and Physiological Genomics.

Elected to the Institute of Medicine in 2009, Saper is also a Fellow of the American Academy of Neurology, the American Association for the Advancement of Science, and the Royal College of Physicians in London. He is a member of the American Association of Physicians.

Saper has received a Javits Neuroscience Investigator Award from the National Institutes of Health (NIH) and was named one of the "100 Most Frequently Cited Neuroscientists" by the Institute for Scientific Information. The author of over 200 scientific papers and co-author of the textbook Plum and Posner's Diagnosis of Stupor and Coma, he has served as Vice President and Councilor of the American Neurological Association and as Chairman of the Program Committee of the Society for Neuroscience.


'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Related medicine news :

1. Johns Hopkins African bioethics program receives 5-year continuation grant from NIH
2. Aging Brain Care model receives $7.8 million in CMS innovation funding
3. The W3 Project Receives Support from Doulton for Emergency Relief Efforts
4. High value health care collaborative receives $26 million health care innovation grant
5. Pediatric kidney expert receives Young Investigator Award from American Transplant Congress
6. Surgeon General receives 2012 Distinguished Public Service Award from internal medicine physicians
7. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
8. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
9. Markey receives $6.25 million to study deadly blood and bone marrow disease
10. UC San Diego Superfund Research Program receives $15 million grant renewal
11. Dr. Arthur Slutsky, vice-president of research at St. Michaels, receives lifetime award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Coppin Insurance Agency, an insurance and financial planning ... the Cape Coral area, is embarking on a charity drive with the goal of ... The Harry Chapin Food Bank of Southwest Florida works to provide fresh and nutritious ...
(Date:12/8/2016)... ... December 08, 2016 , ... Bill Mull Agencies, a ... in and around central Kansas, is joining the Youth Horizons organization for a ... , Headquartered in Wichita, Youth Horizons works to empower area children from unstable, ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Today, MHA and mental ... mental health systems reform legislation in more than fifty years. We applaud the ... of our elected officials to improving mental health services and supports in our ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a ... smoothing and tightening the skin of the face to create more youthful features. ... with very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... Technology, S.L. (“Presence”) for a purchase price of approximately $17.4 million (net ... Presence’s annual revenue is approximately $13.2 million. Headquartered in Barcelona, Spain, Presence ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... , Dec. 8, 2016 Bodycad announced ... for improving the accuracy, reproducibility and speed for ... long and small bone orthopaedic applications. These patents ... creating personalized orthopaedic restorations based on each patient,s ... restorations, the company harnesses the world,s first suite ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
Breaking Medicine Technology: